Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene a

Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma | Science Translational Medicine

Ciltacabtagene autoleucel–associated non-ICANS neurotoxicities are driven by high CD4+ CAR T cell expansion.